KNSA
Kiniksa Pharmaceuticals, Ltd.
NASDAQ · Healthcare · Biotechnology · BM
$77.91
−3.18%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.08x
- Net debt / EBITDA
- -1.49x
Liquidity & coverage
- Current ratio
- 3.90x
- Quick ratio
- 3.49x
- Cash ratio
- 3.07x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $497.4M
Cash & dividend
- FCF / debt
- 20.58x
- Cash flow / debt
- 20.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026